Evidence map›Paper›PMID 42794976›Full record

ArticleCancers2026

Dynamic Plasma KRAS ctDNA Profiling Identifies Treatment Response and Nascent Resistance in Metastatic Non-Small-Cell Lung Cancer: A Pilot Study.

Valentina Buzzi, Greta Berti, Michele Santillo, Arianna Belli, Elisabetta Rosi, Giulia Favarato, Federico Lavorini, Sara Tomassetti, Annarosa Arcangeli, Mauro Iannopollo and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Valentina BuzziDepartment of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.
Greta BertiMedical Oncology, S. Jacopo Hospital, 51100 Pistoia, Italy.ORCID 0009-0007-9389-6318
Michele SantilloDepartment of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.ORCID 0009-0000-0876-4521
Arianna BelliPulmonology and Intensive Care Unit, Careggi University Hospital, 50134 Florence, Italy.
Elisabetta RosiPulmonology and Intensive Care Unit, Careggi University Hospital, 50134 Florence, Italy.ORCID 0009-0008-4763-6395
Giulia FavaratoInterventional Pulmonology Unit, Careggi University Hospital, 50134 Florence, Italy.
Federico LavoriniDepartment of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.ORCID 0000-0002-3293-2123
Sara TomassettiDepartment of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.
Annarosa ArcangeliDepartment of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.
Mauro IannopolloMedical Oncology, S. Jacopo Hospital, 51100 Pistoia, Italy.ORCID 0000-0002-5136-5515
Elena LastraioliDepartment of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.ORCID 0000-0002-1531-8973

Funding

Fondazione Cassa di Risparmio di Pistoia e Pescia CaPoSUniversity of Florence ex60%
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

KRASliquid biopsylung cancertherapy monitoring

Identifiers

PMID42794976
PMCPMC13604566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.